Entero Healthcare Solutions Limited IPO Message Board (Page 9)

Hi,
Can you suggest which banks allow applying IPOs from the flex (or sweep) FDs without breaking till allotment?
I have used Kotak, ICICI and AU Bank. Details as under-
Kotak - ActivMoney (FD's Auto Created)
ICICI - MoneyMultiplier (FD's can be manually created online)
AU Bank - FlexFD (FDs need to be created by visiting branch or video call)

Does Bank of Baroda, HDFC, and IDFC Bank have such facility?
TIA

​@IPOFreak Hdfc bank does not allow it, i do not know about BOB and IDFC..

Reminds of these lines ...

बरसाती मेंढक

बस दो रोज़ टर्राते हैं
बारिश के जाते ही
न जाने कहाँ खो जाते हैं

It was too early to celebrate. Few have come back and should be shown the door soon.

Oh ok. I thought you are referring to the company. Was my fist msg.

Any Grey mrkt updates ?

As per GMP updates, from not so impressive debut of 10% few days back, current GMP is close to zero. Will be interesting to see how this counter will fare.

Hyatt Backed
Juniper Hotels To Come With It's
1800 cr IPO Soon

An Interesting One

Full Fresh Capital of 1800 cr will turnaround the company

Expected In This Month Itself

First time I'm seeing such a coordinated effort by brand new accounts to promote an IPO - it's quite irritating since it prevents genuine participants from engaging in discourse that could help us decide to invest

Earlier I thought the market cap was ~3000 Cr (this number is still reflecting here on CG), but it seems to be ~5500 Cr. At the earlier number this looked very interesting to me, but at the actual MCap, the case isn't so compelling

1.4-1.5x revenue for a distribution biz is very expensive, but the one question is that good Healthcare cos like Apollo, Max, Global Health etc. trade at hefty premiums in general (40-50x EBITDA), and Entero is coming at a similar valuation with sharper growth. Can a distribution biz growing faster than a consumer biz, trade at similar multiples?

I guess we'll find out, but all these fake posts are really putting me off from this one

​@Admin @ Chittorgarh.com New account should not be able to comment for first 2 weeks at least in order to control fake promotion and any kind of nuisance.

​@Anuwak It is nice suggestion but not too practical as it will devoid the genuine newbies from participating. Nahin?
Observed that whatever new IDs were created towards promotion here were promptly removed by Admin yesterday and even today.

​@Admin @ Chittorgarh.com Some new members here are suspicious. Quoting numbers exact to second decimal point. These are new members. Mostly for promotion. Pls review once. Thanks

Most of these new comments I see added are whatever is available basis DRHP. Don’t see any suspicion in this. I think they have also added good point of view for discussion. I feel start-up valuations should be looked at differently from historical companies (which should be on projected growth). Company is profitable already, and business module looks strong. I think those who are looking at marginal listing gains with long term holding capacity should subscribe.

​@UjwalG I totally agree with you. There is a pattern how new members are countering all the post of some senior members.

Ideal candidate for negative listing

Too my mind there are so many options why we should go for this one when there is ifs and buts..Just my opinion...AS I m always playing Safe Game🙏

Looks like many new accounts are created to defend the views of our beloved senior members.
Very much suspicious.
Such new members can react here as well. Let's dedicate a thread for them. : )

Yes , some repetitive messages are coming which indicate promotion by some aspirants. They are providing with useless/nonsignificant data.
It is nothing doing being engaged in a debutant loss maker's statics .
As I have seen post ipo :
Eps 4.7 , p/e 268 (based on 6m available) , P/B 8.7 , mcap to revenue 1.57 and it's very high for a stranger even it may claim as a market leader where we don't have any transparent view of the market referred to .

It remains mentioned that somebody may have high hope comparing it with Medplus( which has visible business ) Price 627 ,eps 0.45 , p/e 1394 , p/ b 6.5 and
mcap to revenue about 1.64 .

If anybody thinks "Khela Hobe " ,it is a different issue.

At this point it looks akin to Paytm .

Fellow readers and members
Please - please - please

Kindly take decision on behalf of your own assessment and research

Atleast 15 new accounts just created TODAY and all are heavily promoting this IPO on the basis of insane arguments .

It's purely look organised and sponsored

Don't be fooled by such dirty game.

In a way they are hurting even this IPO's interest it self

Invest onthe merit of your own research

Good discussion going on here. Ideally we should look at the growth potential whish is there. Good amount of money raised is going to be used for acquisitions so expect significant pickup in revenue immediately.

Currently three organized players in industry having ~7-8% market share total which is expected to go upto ~25-30% incoming 4-5 years so expect an even higher cagr of growth going forward driven by both organic and acquisitions. Which should give operating leverage leading to enhanced profitability in a business where scale is the biggest factor.

No doubt Pat losses in last 3 years have been concerning, operating level they have been profitable from year 2 iyeself being in hypergrowth model which is commendable. Seeing profits in H1 24 and improving margin profiles has been giving some positives to bet on this.

But yes need a different lens to understand and look at these fast growing business other than only current P/E which can be shortshited.

Shortsighted*

Shortsighted*

​@Admin @ Chittorgarh.com if you could look for the comments of these people who are defending the company with accurate facts and praises. i have seen 6-7 of these accounts created recently. It seems they just manipulating us to float this ipo. Kindly remove them.

#Offtopic

Which is the best broker for momentum trading for breakouts?

Like GTT buy option with limit price and stoploss too

JG Chemicals to hit in Feb end
Around 450 cr issue

CM rating is 38.
Will decide on last day afternoon.

Experts please suggest about Flair writing??.....number are bad....should we book loss ?

It's difficult to compare this iPod with Gland Pharma due to following .
1. Gland is giant company as compared to entero.
2. Gland was continuously profit making company.

3.Gland is pharma company as entero is pharma distributor.

It's difficult to apply full force here. Can apply retail and test your luck...

For a gambler: All avoids are not avoidable .
For a greedy man : All avoidables are not avoids.
For a common : Dwindling away in yes/no .
For a reasonable man : jis talaw ko pani nahi pina usko najdik bhi nahi jana .
Kyse koi pani pe li toh !

Lekin mukhia ka Himmat ko daad dena padega.

Did some study on the Company

In 6 years growing from 0 to close to 4000 crore (annualized FY24) is impressive..

30%+ CAGR YOY in a sector which is filled only with regional players.. it's highly regional sector.. So again this is good for the Company..

Loan repayment of 142-143 crores may generate another 12-15 crores profit based on interest saved.. assuming max profit after interest saving.. Annualized profit may range between 30-40 crores.

There are no listed peers as such which can be directly Compared with this Company. Even Medplus is not a comparable as such given Medplus is a retail chain while Entero is B2B (Distributors to Pharmacies, Hospitals, clinics, etc.)

But extremely high valuation even then.. They are like new edge startups trying to define this market..

Personally, I feel it looks good for Long term when they will be able to optimize their Warehouse, distribution network in future resulting in better Profitilabity. However, it is one thing to grow and another is to sustain it..

As for listing gains, it looks dicey according to me.. 😶😶

​@CoolAsh After a while someone comes with an issue price above Rs 1000. Sector is enticing, and likewise the companies that operate in it can do well. Entero is expensive and will remain so, as currently sentiments overpower fundamentals. Reminds of Mamaearth, Nykaa, Paytm

May take some risks in retail around 3 PM.

Definitely no BHNI as it may entail 4-5 Lakh worth shares (looking at current subscription)

Company is surely good for Long term especially in the sector they are in..

Think... Pharma distribution is so big of a market in India yet no listed player ever in this space.. why?

Because it's highly fragmented..

So surely this Company will be in my radar. As of now, will wait till 3 PM. Personally, I think we will see QIB subscriptions.